{"id":"cutaquig","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["subcutaneous immunoglobulin","Octapharma","Immunoglobulin (human) subcutaneous 16.5% Solution for injection (165 mg/mL)"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Cutaquig","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:38:58.651646+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:39:05.686899+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cutaquig","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:39:06.457322+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"f199187a-de4e-2047-0aee-b6d93390b3d2","title":"CUTAQUIG (IMMUNOGLOBULIN G) SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]"},"ecosystem":[],"_scrapedAt":"2026-03-28T01:08:13.129Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:39:09.056656+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04354129","phase":"","title":"Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-04-01","conditions":"Primary Immune Deficiency Disorder, Secondary Immune Deficiency","enrollment":36},{"nctId":"NCT03939533","phase":"PHASE3","title":"Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases","status":"COMPLETED","sponsor":"Octapharma","startDate":"2019-10-17","conditions":"Primary Immune Deficiency Disorder","enrollment":64},{"nctId":"NCT05986734","phase":"","title":"Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies","status":"UNKNOWN","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2022-09-01","conditions":"Primary Immunodeficiency Diseases (PID)","enrollment":100},{"nctId":"NCT03677557","phase":"PHASE4","title":"Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2018-09-19","conditions":"Primary Immunodeficiency Disease, Secondary Immunodeficiency","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":13,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Cutaquig","genericName":"Cutaquig","companyName":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","companyId":"federal-research-institute-of-pediatric-hematology-oncology-and-immunology","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:39:09.056656+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}